|
Drug trade dispute does not affect the export of Chinese drugs - drugs disputes, the export of drug by wgverbv dfbdfb
 |
|
|
Drug trade dispute does not affect the export of Chinese drugs - drugs disputes, the export of drug by WGVERBV DFBDFB
|
|
| Article Posted: 03/15/2011 |
| Article Views: 132 |
| Articles Written: 1361 - MORE ARTICLES FROM THIS AUTHOR |
| Word Count: 910 |
| Article Votes: 0 |
|
Drug trade dispute does not affect the export of Chinese drugs - drugs disputes, the export of drug |
|
|
|
|
|
Business,Business News,Business Opportunities
|
|
Year ago in May, the pharmaceutical industry's exports grew 22.9%. Analysts said the international public opinion for the quality of Chinese products had some doubts and a series of trade disputes did not affect China's export of pharmaceutical products.
7 14, the National Development and Reform Commission (NDRC) announced on its website, China's pharmaceutical industry, the operation of the first five months. Data show that in January the pharmaceutical industry on the export delivery value of -5 36.8 billion yuan, up 22.9%. Among them, chemical API 16.8 billion, an increase of 28.5%, remains the backbone of China's pharmaceutical exports; chemicals Preparation 3.21 billion yuan, an increase of 15.7%.
Last couple of years, Chinese exports of food, medicines and daily necessities have encountered a number of disputes. Such as "drug poisoning incident in Panama", "US-bound heparin adverse events", "toothpaste containing diethylene glycol incident", making the quality of Chinese exports by some people's doubts; and India, the United States on China's system Pharmaceutical companies Industry-initiated anti-dumping, anti-trust litigation, but also to API Cast a shadow over the export trade. This year in April, has a three-year-old stalemate involving the U.S. antitrust case of vitamin C regeneration of twists and turns, North China Pharmaceutical Co., Ltd. is also one of the United States as a defendant.
Development and Reform Commission released data showing that such disputes did not seem to export to the Chinese pharmaceutical industry in significant impact. First half of 2006, the pharmaceutical industry and an export value of 29.5 billion yuan, an increase of 23.9%; first half of 2007, the pharmaceutical industry and an export value of 37.9 billion yuan, an increase of 20.6%. The first five months of this year's export growth reached 22.9%, essentially flat with the previous years level.
"The past few years, China's pharmaceutical exports, has maintained more than 20% growth rate, the situation is better." Vice president of pharmaceutical business in China Zhu Changhao told "financial" journalists, consumer demand for drugs are rigid demand, not prone to major changes within a short time, while China's exports of chemical raw are also quite competitive, even about the international market, so is still welcomed by other countries, will not be the impact of individual cases or disputes.
China Galaxy Securities Co., Ltd. element and the pharmaceutical industry analysts said the pharmaceutical industry, chemical raw prices of export growth even told about. Recent years, some domestic enterprises because of environmental pressures, the export tax rebate adjustment, there had been cut and shutdown APIs, resulting in its intermediate penicillin industrial salt, vitamins and other products is expected to supply, so prices soaring. According to Chinese medicine Health Products Import and Export Chamber of Commerce of the United States, India, Germany, Japan and the Netherlands is China's top five bulk drug export destination. While the addition of India, the first three months of this year, the other four countries of China Pharmaceutical exports of raw materials have different levels decreased, but export prices in general grew by 35%, and the final export value also increased to varying degrees.
The same time, diversification of export markets bulk drugs yielded positive results, this year in January -3 Iraq on our country, Tajikistan, Latvia's exports to achieve a larger increase.
However, China's export growth pharmaceutical industry is facing many difficulties. Development and Reform Commission's analysis that the energy crisis, rising raw material prices is the current development of China's pharmaceutical industry is facing the biggest challenge. This year, the snow disaster, earthquake and the impact of soaring international oil prices, China's coal, electricity, oil, transport, agricultural, chemical raw materials and other basic factors of production prices rose markedly different degrees, increase the production of pharmaceutical companies in China cost. Meanwhile, with the continuous environmental monitoring efforts to strengthen governance, the environmental costs of large pharmaceutical companies, coupled with appreciation of the RMB, the export tax rebate rate down, pharmaceutical companies operating in China face enormous cost pressure.
Zhu Changhao that, along with chemical raw production costs and prices, whether the export of the pharmaceutical industry to maintain growth, depends on whether the international market can withstand the ever rising price.
According to Chinese Medicine & Health Products Import and Export Chamber of Commerce estimated in 2008 the export price of China's API will remain high, the annual export volume is expected to grow 20%; and, as the global pharmaceutical outsourcing market, outsourcing manufacturing and the continuous demand expand, and enhance the ability of pharmaceutical companies in China, Western medicine's exports in 2008 will continue to maintain a rapid growth momentum, a new pharmaceutical industry export growth.
According to data provided by NDRC, in addition to exports, our production and sales of the pharmaceutical industry has maintained rapid growth, significant improvement in overall efficiency. January -5 months total industrial output value 311.6 billion yuan, up 29%; to achieve sales volume of 295.54 billion yuan, up 30.3%; average sales rate of 94.8% over the same period by 0.9 percentage points. First five months of the pharmaceutical industry to achieve a total profit of 27.8 billion yuan, up 43.6%, higher than the national industry average of 22.7 percent, ranking the 12 major industrial sectors of the third. I am China Agriculture Net writer, reports some information about technics cassette deck , reel tape player.
Related Articles -
technics cassette deck, reel tape player,
|
Rate This Article  |
|
|
|
|
|
Do you Agree or Disagree? Have a Comment? POST IT!
| Reader Opinions |
|
|
|
|
|
